Prostate Cancer Trial, Recruiting (NCT05184790)

Prostate Cancer Trial, Recruiting NCT05184790 Sponsor: University of Sydney Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05184790 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are scheduled to receive radiation therapy for cancer of the brain, breast, head and neck, kidney, liver, pancreas, prostate, or spine — or for a heart rhythm condition — at a participating treatment centre.
You will have a CT planning scan and at least one cone beam CT scan (a type of imaging done during treatment) as part of your radiation therapy.
If you are being treated for liver, pancreas, prostate, or spine cancer, or a heart rhythm condition, you will also have X-ray imaging taken during your radiation treatment sessions.
You are willing and able to sign a consent form agreeing to take part in the study.

Who may not be able to join:

You are under 18 years of age.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Paul Keall, Professor

Phone: +61 2 8627 1185

Australian sites

Royal North Shore Hospital, Saint Leonards, New South Wales

Princess Alexandra Hospital, Woolloongabba, Queensland

Alfred Health, Melbourne, Victoria

Peter MacCallum Cancer Centre, Melbourne, Victoria

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05184790

Sponsor: University of Sydney

Phase: Not Applicable

Status: Recruiting

Condition: Prostate Cancer

Trial contact: +61 2 8627 1185

More information: https://clinicaltrials.gov/study/NCT05184790

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are scheduled to receive radiation therapy for cancer of the brain, breast, head and neck, kidney, liver, pancreas, prostate, or spine — or for a heart rhythm condition — at a participating treatment centre.
You will have a CT planning scan and at least one cone beam CT scan (a type of imaging done during treatment) as part of your radiation therapy.
If you are being treated for liver, pancreas, prostate, or spine cancer, or a heart rhythm condition, you will also have X-ray imaging taken during your radiation treatment sessions.
You are willing and able to sign a consent form agreeing to take part in the study.

Who may not be able to join:

You are under 18 years of age.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Sydney

Registry

ClinicalTrials.gov

Start date

28 February 2023

Est. completion

31 January 2028

Where this trial is recruiting

🇦🇺 Australia

4 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Accuracy of markerless tracking

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov